Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuniko Sunami

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Histopathology|October 11, 2022
Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull baseNaohiro Makise, Tatsunori Shimoi, Kuniko Sunami, et al.
International Journal of Clinical Oncology|December 19, 2023
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trialSae Ishimaru, Tatsunori Shimoi, Kuniko Sunami, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2016
Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapyYusuke Takagi, Yukio Hosomi, Makoto Nagamata, et al.
Cancer Science|October 1, 2024
Leveraging non-coding regions to guarantee the accuracy of small-sized panel-based tumor mutational burden estimatesTakahiro Nishino, Mio Yumura, Kuniko Sunami, et al.
Cancer Chemotherapy and Pharmacology|November 4, 2015
Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumorsYutaka Fujiwara, Hiroshi Nokihara, Yasuhide Yamada, et al.
Thoracic Cancer|October 9, 2020
Lung adenocarcinoma in a patient with a cis EGFR L858R-K860I doublet mutation identified using NGS-based profiling test: Negative diagnosis on initial companion test and successful treatment with osimertinibHiroto Onozawa, Haruhiro Saito, Kuniko Sunami, et al.
Clinical Lung Cancer|November 22, 2016
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung CancerHitomi Sumiyoshi Okuma, Hidehito Horinouchi, Shinsuke Kitahara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2016
Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the LungTsugumasa Kamata, Kuniko Sunami, Akihiko Yoshida, et al.
Japanese Journal of Clinical Oncology|April 19, 2025
Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencingAkito Fukuda, Takaaki Mizuno, Tatsuya Yoshida, et al.
The Oncologist|September 28, 2014
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancerYusuke Takagi, Yukio Hosomi, Kuniko Sunami, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Histopathology|October 11, 2022
Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull baseNaohiro Makise, Tatsunori Shimoi, Kuniko Sunami, et al.
International Journal of Clinical Oncology|December 19, 2023
Platform trial for off-label oncology drugs using comprehensive genomic profiling under the universal public healthcare system: the BELIEVE trialSae Ishimaru, Tatsunori Shimoi, Kuniko Sunami, et al.
Cancer Chemotherapy and Pharmacology|January 29, 2016
Phase II study of oral vitamin B12 supplementation as an alternative to intramuscular injection for patients with non-small cell lung cancer undergoing pemetrexed therapyYusuke Takagi, Yukio Hosomi, Makoto Nagamata, et al.
Cancer Science|October 1, 2024
Leveraging non-coding regions to guarantee the accuracy of small-sized panel-based tumor mutational burden estimatesTakahiro Nishino, Mio Yumura, Kuniko Sunami, et al.
Cancer Chemotherapy and Pharmacology|November 4, 2015
Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumorsYutaka Fujiwara, Hiroshi Nokihara, Yasuhide Yamada, et al.
Thoracic Cancer|October 9, 2020
Lung adenocarcinoma in a patient with a cis EGFR L858R-K860I doublet mutation identified using NGS-based profiling test: Negative diagnosis on initial companion test and successful treatment with osimertinibHiroto Onozawa, Haruhiro Saito, Kuniko Sunami, et al.
Clinical Lung Cancer|November 22, 2016
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung CancerHitomi Sumiyoshi Okuma, Hidehito Horinouchi, Shinsuke Kitahara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 1, 2016
Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the LungTsugumasa Kamata, Kuniko Sunami, Akihiko Yoshida, et al.
Japanese Journal of Clinical Oncology|April 19, 2025
Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencingAkito Fukuda, Takaaki Mizuno, Tatsuya Yoshida, et al.
The Oncologist|September 28, 2014
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancerYusuke Takagi, Yukio Hosomi, Kuniko Sunami, et al.
Pageof 7